Trial intelligence / Profile preview

EUS Guided Adalimumab for Crohn's Perianal Fistulas

NCT00517296Phase 4Completed

Sponsor
Vanderbilt University Medical Center
Start
Jan 2008
Primary completion
Dec 2014
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of adalimumab in Crohn's disease, perianal fistula, sponsored by Vanderbilt University Medical Center. Started Jan 2008; status: completed.

02

Drugs

03

Conditions

Crohn's diseaseperianal fistula

Beyond the preview

Go deeper on NCT00517296.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00517296.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call